143 related articles for article (PubMed ID: 2111664)
1. [New treatments for urogenital toxicity of anti-neoplastic chemotherapy].
Shibuya M; Hirosawa A; Niitani H
Gan To Kagaku Ryoho; 1990 Apr; 17(4 Pt 2):950-6. PubMed ID: 2111664
[TBL] [Abstract][Full Text] [Related]
2. Effects of sodium thiosulfate in combination therapy of cis-dichlorodiammineplatinum and vindesine.
Hirosawa A; Niitani H; Hayashibara K; Tsuboi E
Cancer Chemother Pharmacol; 1989; 23(4):255-8. PubMed ID: 2538252
[TBL] [Abstract][Full Text] [Related]
3. [Combination effects of cis-dichlorodiammineplatinum (II) and sodium thiosulfate on renal dysfunction].
Hirosawa A; Sakai S; Iizuka K; Niitani H; Hayashibara K; Tsuboi E
Gan To Kagaku Ryoho; 1987 Oct; 14(10):2870-5. PubMed ID: 3662543
[TBL] [Abstract][Full Text] [Related]
4. [Effect of sodium thiosulfate on the antitumor effect and nephrotoxicity of CDDP in human gastric cancer transplanted in nude mice].
Saito D; Fujii T; Yoshida S; Ohkura H; Oguro Y
Gan To Kagaku Ryoho; 1989 Mar; 16(3 Pt 1):379-85. PubMed ID: 2930203
[TBL] [Abstract][Full Text] [Related]
5. [Clinical investigation of cis-platinum nephrotoxicity in 244 cases of primary lung cancer].
Soejima A; Inoue T; Suzuki M; Waku M; Nakabayashi K; Kitamoto K; Nagasawa T
Nihon Jinzo Gakkai Shi; 1992 Jul; 34(7):801-6. PubMed ID: 1479719
[TBL] [Abstract][Full Text] [Related]
6. [A clinical evaluation of the protective effect of fosfomycin (FOM) against the cis-diamminedichloroplatinum (CDDP)-induced nephrotoxicity].
Saito M; Masaki T; Kato H; Numasaka K
Hinyokika Kiyo; 1988 May; 34(5):782-9. PubMed ID: 3051938
[TBL] [Abstract][Full Text] [Related]
7. Protection against cisplatin-induced toxicities by N-acetylcysteine and sodium thiosulfate as assessed at the molecular, cellular, and in vivo levels.
Dickey DT; Wu YJ; Muldoon LL; Neuwelt EA
J Pharmacol Exp Ther; 2005 Sep; 314(3):1052-8. PubMed ID: 15951398
[TBL] [Abstract][Full Text] [Related]
8. [Effect of sodium thiosulfate on cisplatin-induced ototoxicity].
Lou WH
Zhonghua Er Bi Yan Hou Ke Za Zhi; 1990 Aug; 25(4):208-10, 255. PubMed ID: 2076324
[TBL] [Abstract][Full Text] [Related]
9. [Two-route chemotherapy using a combination of anticancer agents and antidotes].
Iwamoto Y; Baba T
Gan To Kagaku Ryoho; 1985 Mar; 12(3 Pt 2):766-72. PubMed ID: 4039123
[TBL] [Abstract][Full Text] [Related]
10. [Effects of combination chemotherapy with cis-diamminedichloroplatinum (II) (CDDP) on renal function in patients with urogenital malignancies].
Kawamura J; Hida S; Higashi Y; Yamauchi T; Soeda A; Yoshida O
Hinyokika Kiyo; 1985 Feb; 31(2):207-21. PubMed ID: 4040315
[TBL] [Abstract][Full Text] [Related]
11. [Determination of urinary N-acetyl-beta-D-glucosaminidase (NAG) excretion as a parameter of nephrotoxicity due to cis-platin and the effect of fosfomycin (FOM) on its nephrotoxicity].
Matsuoka R; Inoue T; Miyamura K; Mizutani K; Koike S; Mori H; Kigawa T
Nihon Sanka Fujinka Gakkai Zasshi; 1986 Nov; 38(11):2037-44. PubMed ID: 3794453
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of two-route chemotherapy using cis-diamminedichloroplatinum(II) and its antidote, sodium thiosulfate, in combination with angiotensin II in a rat limb tumor.
Kuroiwa T; Aoki K; Taniguchi S; Hasuda K; Baba T
Cancer Res; 1987 Jul; 47(14):3618-23. PubMed ID: 3594429
[TBL] [Abstract][Full Text] [Related]
13. Delayed administration of sodium thiosulfate in animal models reduces platinum ototoxicity without reduction of antitumor activity.
Muldoon LL; Pagel MA; Kroll RA; Brummett RE; Doolittle ND; Zuhowski EG; Egorin MJ; Neuwelt EA
Clin Cancer Res; 2000 Jan; 6(1):309-15. PubMed ID: 10656463
[TBL] [Abstract][Full Text] [Related]
14. Comparative study of the acute nephrotoxicity from standard dose cisplatin +/- ifosfamide and high-dose chemotherapy with carboplatin and ifosfamide.
Hartmann JT; Fels LM; Franzke A; Knop S; Renn M; Maess B; Panagiotou P; Lampe H; Kanz L; Stolte H; Bokemeyer C
Anticancer Res; 2000; 20(5C):3767-73. PubMed ID: 11268452
[TBL] [Abstract][Full Text] [Related]
15. [Effect of sodium thiosulfate on the anti-tumor effect and nephrotoxicity of CDDP in human gastric cancer].
Saito D; Fujii T; Yoshida S; Ohkura H; Oguro Y
Gan To Kagaku Ryoho; 1990 Apr; 17(4 Pt 2):959-63. PubMed ID: 2188616
[No Abstract] [Full Text] [Related]
16. Ifosfamide-induced subclinical tubular nephrotoxicity despite mesna.
Goren MP; Wright RK; Horowitz ME; Pratt CB
Cancer Treat Rep; 1987 Feb; 71(2):127-30. PubMed ID: 2879626
[TBL] [Abstract][Full Text] [Related]
17. [Pharmacokinetic study of cisplatin and sodium thiosulfate in two-route-infusion chemotherapy].
Ikeda K
Gan To Kagaku Ryoho; 1986 Apr; 13(4 Pt 1):1026-31. PubMed ID: 3963847
[TBL] [Abstract][Full Text] [Related]
18. Urinary proton magnetic resonance studies of early ifosfamide-induced nephrotoxicity and encephalopathy.
Foxall PJ; Singer JM; Hartley JM; Neild GH; Lapsley M; Nicholson JK; Souhami RL
Clin Cancer Res; 1997 Sep; 3(9):1507-18. PubMed ID: 9815837
[TBL] [Abstract][Full Text] [Related]
19. [Measurement of creatinine clearance and urinary NAG for the evaluation of cis-platinum induced nephrotoxicity].
Kubota A; Yoshida T; Tsukuda M; Furukawa S; Miyata K; Mochimatsu I; Sawaki S
Gan To Kagaku Ryoho; 1989 Aug; 16(8 Pt 1):2599-605. PubMed ID: 2774590
[TBL] [Abstract][Full Text] [Related]
20. [Efficacy of combined use of sodium thiosulfate in percutaneous isolated liver chemoperfusion of cisplatin under complete hepatic venous isolated and charcoal hemoperfusion].
Kusunoki N; Ku Y; Tominaga M; Iwasaki T; Muramatsu S; Sugimoto T; Kuroda Y
Gan To Kagaku Ryoho; 1997 Sep; 24(12):1781-4. PubMed ID: 9382532
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
